278 related articles for article (PubMed ID: 1549569)
1. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
Wucherpfennig KW; Höllsberg P; Richardson JH; Benjamin D; Hafler DA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2110-4. PubMed ID: 1549569
[TBL] [Abstract][Full Text] [Related]
2. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
3. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
[TBL] [Abstract][Full Text] [Related]
4. Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients.
Miyano-Kurosaki N; Kira J; Barnor JS; Maeda N; Misawa N; Kawano Y; Tanaka Y; Yamamoto N; Koyanagi Y
Microbiol Immunol; 2007; 51(2):235-42. PubMed ID: 17310092
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.
Höllsberg P; Wucherpfennig KW; Ausubel LJ; Calvo V; Bierer BE; Hafler DA
J Immunol; 1992 May; 148(10):3256-63. PubMed ID: 1374452
[TBL] [Abstract][Full Text] [Related]
7. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
8. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
10. Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Makino M; Azuma M; Wakamatsu SI; Suruga Y; Izumo S; Yokoyama MM; Baba M
Clin Diagn Lab Immunol; 1999 May; 6(3):316-22. PubMed ID: 10225829
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
[TBL] [Abstract][Full Text] [Related]
12. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
[TBL] [Abstract][Full Text] [Related]
13. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
15. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
16. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
Azimi N; Jacobson S; Leist T; Waldmann TA
J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
[TBL] [Abstract][Full Text] [Related]
17. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP.
Enose-Akahata Y; Oh U; Ohayon J; Billioux BJ; Massoud R; Bryant BR; Vellucci A; Ngouth N; Cortese I; Waldmann TA; Jacobson S
Ann Clin Transl Neurol; 2019 Aug; 6(8):1383-1394. PubMed ID: 31402625
[TBL] [Abstract][Full Text] [Related]
19. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
Mukae H; Kohno S; Morikawa N; Kadota J; Matsukura S; Hara K
Microbiol Immunol; 1994; 38(1):55-62. PubMed ID: 8052162
[TBL] [Abstract][Full Text] [Related]
20. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]